• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Visolyr and HITLAB Partner to Advance AI Solutions for Women’s Health and Cardiometabolic Disease

By: PRUnderground
May 27, 2025 at 18:43 PM EDT

(PRUnderground) May 27th, 2025

Visolyr, a digital health platform focused on AI-powered clinical solutions, has partnered with HITLAB, a leading health innovation research lab, to accelerate the development and validation of a breakthrough Generative AI platform designed to transform healthcare delivery.

Under a strategic services agreement, HITLAB will support Visolyr in building and refining its Generative and Agentic AI platform for healthcare through rigorous validation research, publication, business model development, investor engagement, and strategic partnerships. The collaboration aims to bring to market a clinically validated solution that improves clinical documentation, enhances decision support, elevates patient engagement and education, and strengthens medication management.

Visolyr’s AI platform is engineered to accelerate digital health transformation by integrating Generative AI, AI agents, and intelligent automation directly into clinical workflows. With a focus on women’s health and high-burden conditions such as cardiometabolic diabetes—particularly in patients with kidney disease and hypertension—Visolyr delivers personalized, proactive, and coordinated care. The platform enables enterprise-wide AI deployments that enhance clinician efficiency and improve patient experiences at the point of care.

Through its participation in the NVIDIA Inception program, Visolyr has deployed NVIDIA Inference Microservices (NIM) to deliver sub-second, context-aware AI responses. This has powered Visolyr’s latest demo capabilities, which include hybrid AI workflows, Retrieval-Augmented Generation (RAG) automation, and optimized routing.

“HITLAB is committed to accelerating the adoption of impactful technologies that address unmet healthcare needs,” said Dr. Stan Kachnowski, Chair of HITLAB. “Our collaboration with Visolyr reflects our shared vision of using cutting-edge AI to streamline clinical processes, improve outcomes, and reduce costs.”

Visolyr Founder and CEO Michael Joseph added, “Our partnership with HITLAB is a critical milestone in our mission to bring context-aware AI to the point of care. Together, we are advancing a platform that not only empowers clinicians but also personalizes the care journey for patients.”

HITLAB, known for initiatives such as the HITLAB World Cup, Women’s Health Tech Initiative, and Breakthrough Alliance, will also help position Visolyr’s innovation within the broader healthcare ecosystem through seminars, conferences, and thought leadership.

About Visolyr
Visolyr is a healthcare AI platform that enables enterprise-scale deployment of Generative AI and intelligent agents within clinical workflows. Focused on enhancing clinical decision-making and streamlining care for complex chronic conditions, Visolyr is on a mission to improve health outcomes, provider productivity and operational efficiency through next-generation technology at the forefront of AI innovation.

About HITLAB

HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services to improve health delivery around the world.

At HITLAB, we believe technology and health can work together to improve the quality of health delivery and healthcare worldwide. We use rigorous research and evidence-based methods to identify the best digital health solutions for each of our partners.

The post Visolyr and HITLAB Partner to Advance AI Solutions for Women’s Health and Cardiometabolic Disease first appeared on

Press Contact

Name: Rachel Fredman
Phone: 516-310-1583
Email: Contact Us

Original Press Release.

More News

View More
Amazon Stock Rally Hits New Highs: Buy Into Earnings?
July 22, 2025
Via MarketBeat
Tickers AMZN GOOGL META
Forget the Hype—TSMC Is the AI Stock That Actually Delivers
July 22, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers AAPL NVDA TSM
Why Lucid’s 36% Rally on Uber Deal Could Be a Game-Changer
July 22, 2025
Via MarketBeat
Topics Electric Vehicles
Tickers GOOG LCID TSLA UBER
Block Levels Up: What S&P 500 Inclusion Means for Investors
July 22, 2025
Via MarketBeat
Topics ETFs Stocks
Tickers XYZ
Steel Dynamics Stock Steady on Long-Term Prospects
July 22, 2025
Via MarketBeat
Topics World Trade
Tickers CLF STLD X
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap